Ameloblastoma: A Review of Recent Molecular Pathogenetic Discoveries

Abstract excerpt

Ameloblastoma is an odontogenic neoplasm whose molecular pathogenesis has only recently been elucidated. The discovery of recurrent activating mutations in FGFR2, BRAF, and RAS in a large majority of ameloblastomas has implicated dysregulation of MAPK pathway signaling as a critical step in the pathogenesis of this tumor. Some degree of controversy exists regarding the role of mutations affecting the sonic...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Head and Neck Surgical Oncology
• Share to Hedgehog Signaling Pathway Studies
• Share to Oral and Maxillofacial Pathology